Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
10.85
+0.35 (3.33%)
At close: Dec 20, 2024, 4:00 PM
10.36
-0.49 (-4.52%)
After-hours: Dec 20, 2024, 6:32 PM EST
Neumora Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 56.76 | 45.48 | 31.12 | 24.55 | 8.39 | 0.25 |
| Research & Development | 193.88 | 142.72 | 91.75 | 55.78 | 17.31 | - |
| Operating Expenses | 250.64 | 188.19 | 122.87 | 80.32 | 25.71 | 0.25 |
| Operating Income | -250.64 | -188.19 | -122.87 | -80.32 | -25.71 | -0.25 |
| Interest & Investment Income | 21.49 | 16.61 | 4.56 | - | - | - |
| Other Non Operating Income (Expenses) | -0.2 | -0.17 | 0.39 | 0.01 | -0.08 | - |
| EBT Excluding Unusual Items | -229.35 | -171.75 | -117.92 | -80.31 | -25.79 | -0.25 |
| Merger & Restructuring Charges | - | - | - | - | -0.7 | - |
| Gain (Loss) on Sale of Investments | - | - | 0.02 | - | - | - |
| Other Unusual Items | - | - | - | - | -3.28 | - |
| Pretax Income | -293.25 | -235.66 | -130.9 | -237.31 | -99.27 | -0.25 |
| Income Tax Expense | 0.45 | 0.27 | - | - | - | - |
| Net Income | -293.7 | -235.93 | -130.9 | -237.31 | -99.27 | -0.25 |
| Net Income to Common | -293.7 | -235.93 | -130.9 | -237.31 | -99.27 | -0.25 |
| Shares Outstanding (Basic) | 158 | 65 | 27 | 22 | 13 | - |
| Shares Outstanding (Diluted) | 158 | 65 | 27 | 22 | 13 | - |
| Shares Change (YoY) | 368.32% | 138.99% | 24.25% | 68.46% | - | - |
| EPS (Basic) | -1.86 | -3.63 | -4.81 | -10.84 | -7.64 | - |
| EPS (Diluted) | -1.86 | -3.63 | -4.81 | -10.84 | -7.64 | - |
| Free Cash Flow | -184.86 | -163.4 | -115.41 | -76.24 | -28.06 | - |
| Free Cash Flow Per Share | -1.17 | -2.51 | -4.24 | -3.48 | -2.16 | - |
| EBITDA | -250 | -187.53 | -122.28 | -79.79 | -25.6 | - |
| D&A For EBITDA | 0.64 | 0.67 | 0.59 | 0.54 | 0.11 | - |
| EBIT | -250.64 | -188.19 | -122.87 | -80.32 | -25.71 | -0.25 |
Source: S&P Capital IQ. Standard template.
Financial Sources.